These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25853309)

  • 1. Theory and practice of supersaturatable formulations for poorly soluble drugs.
    Kawakami K
    Ther Deliv; 2015 Mar; 6(3):339-52. PubMed ID: 25853309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
    Kawakami K
    Adv Drug Deliv Rev; 2012 May; 64(6):480-95. PubMed ID: 22265844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.
    Cerpnjak K; Zvonar A; Gašperlin M; Vrečer F
    Acta Pharm; 2013 Dec; 63(4):427-45. PubMed ID: 24451070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs.
    Gao P; Morozowich W
    Expert Opin Drug Deliv; 2006 Jan; 3(1):97-110. PubMed ID: 16370943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a solid supersaturatable self-emulsifying drug delivery system of docetaxel with improved dissolution and bioavailability.
    Chen Y; Chen C; Zheng J; Chen Z; Shi Q; Liu H
    Biol Pharm Bull; 2011; 34(2):278-86. PubMed ID: 21415541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.
    van Hoogevest P; Liu X; Fahr A
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1481-500. PubMed ID: 21895540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emulsion forming drug delivery system for lipophilic drugs.
    Wadhwa J; Nair A; Kumria R
    Acta Pol Pharm; 2012; 69(2):179-91. PubMed ID: 22568032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microemulsions as drug delivery systems to improve the solubility and the bioavailability of poorly water-soluble drugs.
    He CX; He ZG; Gao JQ
    Expert Opin Drug Deliv; 2010 Apr; 7(4):445-60. PubMed ID: 20201713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of drug delivery technologies in lead candidate selection and optimization.
    Chaubal MV
    Drug Discov Today; 2004 Jul; 9(14):603-9. PubMed ID: 15239979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dropwise additive manufacturing of pharmaceutical products for amorphous and self emulsifying drug delivery systems.
    Içten E; Purohit HS; Wallace C; Giridhar A; Taylor LS; Nagy ZK; Reklaitis GV
    Int J Pharm; 2017 May; 524(1-2):424-432. PubMed ID: 28380390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN
    Expert Opin Drug Deliv; 2011 Nov; 8(11):1501-19. PubMed ID: 21919807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging trends in the stabilization of amorphous drugs.
    Laitinen R; Löbmann K; Strachan CJ; Grohganz H; Rades T
    Int J Pharm; 2013 Aug; 453(1):65-79. PubMed ID: 22569230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.
    Kohli K; Chopra S; Dhar D; Arora S; Khar RK
    Drug Discov Today; 2010 Nov; 15(21-22):958-65. PubMed ID: 20727418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cryogenic grinding on properties of a self-emulsifying formulation.
    Chambin O; Jannin V; Champion D; Chevalier C; Rochat-Gonthier MH; Pourcelot Y
    Int J Pharm; 2004 Jun; 278(1):79-89. PubMed ID: 15158951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical stabilization of low-molecular-weight amorphous drugs in the solid state: a material science approach.
    Qi S; McAuley WJ; Yang Z; Tipduangta P
    Ther Deliv; 2014 Jul; 5(7):817-41. PubMed ID: 25287388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S
    Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of excipients in successful development of self-emulsifying/microemulsifying drug delivery system (SEDDS/SMEDDS).
    Rahman MA; Hussain A; Hussain MS; Mirza MA; Iqbal Z
    Drug Dev Ind Pharm; 2013 Jan; 39(1):1-19. PubMed ID: 22372916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery.
    Brough C; Williams RO
    Int J Pharm; 2013 Aug; 453(1):157-66. PubMed ID: 23751341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melt extrusion with poorly soluble drugs.
    Shah S; Maddineni S; Lu J; Repka MA
    Int J Pharm; 2013 Aug; 453(1):233-52. PubMed ID: 23178213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.